Need Help?

Blood RNA-seq from Mexican DMD patients and healthy controls

These data are part of a study that aimed to assess the potential of blood RNA-seq to track non-invasively disease progression for DMD. In particular, here we focus on a study designed to compare gene expression in blood from DMD patients to that of healthy controls. These data are analysed in the following manuscript: Signorelli, M., Ebrahimpoor, M. et al. (accepted). Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients. To appear in EMBO Molecular Medicine.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001006826 Illumina HiSeq 2500 57
Publications Citations
Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients.
EMBO Mol Med 13: 2021 e13328
9